Company

DURECT Corporation

Headquarters: Cupertino, CA, United States

Employees: 79

CEO: Dr. James E. Brown D.V.M.

NASDAQ: DRRX +5.51%

Market Cap

$16.6 Million

USD as of Jan. 1, 2024

Market Cap History

DURECT Corporation market capitalization over time

Evolution of DURECT Corporation market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of DURECT Corporation

Detailed Description

DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogenous, orally bioavailable small molecule that is in Phase IIb clinical trial to play a regulatory role in lipid metabolism, stress and inflammatory responses, and cell death and survival to treat alcohol-associated hepatitis, as well as completed Phase Ib clinical trial to treat patients with nonalcoholic steatohepatitis. In addition, the company offers POSIMIR, a post-surgical pain product to deliver bupivacaine up to days of in adults; and Methydur to treat attention deficit hyperactivity disorder. It markets and sells its ALZET lines through direct sales force in the United States, as well as through a network of distributors in Japan, Europe, and internationally. The company has strategic collaboration and other agreements with Virginia Commonwealth University Intellectual Property Foundation; Indivior UK Ltd.; and Santen Pharmaceutical Co., Ltd. DURECT Corporation was incorporated in 1998 and is headquartered in Cupertino, California.

Top 1-year algo backtest: +287.69%

$10,000 in March 2023 would now be $38,769 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Stocks & Indices

DURECT Corporation has the following listings and related stock indices.


Stock: NASDAQ: DRRX wb_incandescent

Stock: FSX: DC8 wb_incandescent

Stock: XSTU: DC8 wb_incandescent

Details

Headquarters:

10260 Bubb Road

Cupertino, CA 95014-4166

United States

Phone: 408 777 1417

Fax: 408 777 3577